Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

RapidTEG observation suggests activation of factor VII may overcome argatroban-induced coagulopathy.

Schmitz ML, St Amour ED, Harness HL, McKamie WA, Johnson CE.

J Cardiothorac Vasc Anesth. 2009 Oct;23(5):752-3. doi: 10.1053/j.jvca.2008.08.009. Epub 2008 Oct 22. No abstract available.

PMID:
18948035
[PubMed - indexed for MEDLINE]
2.

Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.

Nielsen VG, Cohen BM, Cohen E.

Acta Anaesthesiol Scand. 2005 Feb;49(2):222-31.

PMID:
15715625
[PubMed - indexed for MEDLINE]
3.

Severe argatroban-induced coagulopathy in a patient with a history of heparin-induced thrombocytopenia.

Gasparovic H, Nathan NS, Fitzgerald D, Aranki SF.

Ann Thorac Surg. 2004 Dec;78(6):e89-91.

PMID:
15560992
[PubMed - indexed for MEDLINE]
4.

Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis.

Genzen JR, Fareed J, Hoppensteadt D, Kurup V, Barash P, Coady M, Wu YY.

Transfusion. 2010 Apr;50(4):801-7. doi: 10.1111/j.1537-2995.2009.02531.x. Epub 2009 Dec 10.

PMID:
20003049
[PubMed - indexed for MEDLINE]
5.

Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII.

Malherbe S, Tsui BC, Stobart K, Koller J.

Anesthesiology. 2004 Feb;100(2):443-5. No abstract available.

PMID:
14739823
[PubMed - indexed for MEDLINE]
6.

Use of argatroban during multi-organ procurement: pharmacokinetics and sequelae in recipient of transplanted liver.

Schwartz JJ, Hatch JM, Book Z, Lonardo N, Hutson WR, Sorensen JB.

Clin Transplant. 2009 Sep-Oct;23(5):705-9. doi: 10.1111/j.1399-0012.2009.01042.x. Epub 2009 Jul 22.

PMID:
19637991
[PubMed - indexed for MEDLINE]
7.

[Changes of blood coagulation factors in vivo due to triiodized x-ray contrast media. (Preliminary report)].

Maurer HJ, Brüster H.

Rontgenblatter. 1972 Mar;25(3):116-20. German. No abstract available.

PMID:
5048540
[PubMed - indexed for MEDLINE]
8.

Argatroban "reversal" is caused by nonphysiologic stimulation of coagulation, not activated factor VII.

Tanaka KA, Szlam F, Koyama K, Levy JH.

J Cardiothorac Vasc Anesth. 2010 Dec;24(6):1026-7. doi: 10.1053/j.jvca.2009.10.020. Epub 2010 Jan 6. No abstract available.

PMID:
20056441
[PubMed - indexed for MEDLINE]
9.

[Should vitamin K be given preoperatively in obstructive jaundice?].

Müller KH, Naber K, Maroske D, Bichler KH, Mayer W, Höge R.

Langenbecks Arch Chir. 1970;327:473-5. German. No abstract available.

PMID:
5521008
[PubMed - indexed for MEDLINE]
10.

[Fibrinogen and factor VII levels in patients under estrogen-progestin therapy].

Tani M, Bossini S, Maffetti G.

Minerva Ginecol. 1991 Nov;43(11):519-24. Review. Italian.

PMID:
1784409
[PubMed - indexed for MEDLINE]
11.

An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and activated partial thromboplastin time.

Engström M, Rundgren M, Schött U.

Acta Anaesthesiol Scand. 2010 Jan;54(1):86-91. doi: 10.1111/j.1399-6576.2009.02082.x. Epub 2009 Aug 31.

PMID:
19719819
[PubMed - indexed for MEDLINE]
12.

The activity state of factor VII in plasma: two pathways for the cold promoted activation of factor VII.

Muller AD, van Deijk WA, Devilée PP, van Dam-Mieras MC, Hemker HC.

Br J Haematol. 1986 Feb;62(2):367-77.

PMID:
3484966
[PubMed - indexed for MEDLINE]
13.

Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban.

Zayac EA, Pivalizza EG, Levine RL.

Anesth Analg. 2008 Jan;106(1):351-2. doi: 10.1213/01.ane.0000297277.95903.6b. No abstract available.

PMID:
18165611
[PubMed - indexed for MEDLINE]
14.

[Role of newly developed technology in blood coagulation disorders].

Matsuo T.

Rinsho Byori. 2002 May;50(5):506-12. Japanese.

PMID:
12078050
[PubMed - indexed for MEDLINE]
15.

The effect of argatroban on activated protein C resistance.

Shaikh S, Van Cott EM.

Am J Clin Pathol. 2009 Jun;131(6):828-33. doi: 10.1309/AJCPVMUS77ZMBEHJ.

PMID:
19461089
[PubMed - indexed for MEDLINE]
Free Article
16.

Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography.

Kashuk JL, Moore EE, Le T, Lawrence J, Pezold M, Johnson JL, Cothren CC, Biffl WL, Barnett C, Sabel A.

J Surg Res. 2009 Sep;156(1):133-8. doi: 10.1016/j.jss.2009.03.046. Epub 2009 May 3.

PMID:
19577246
[PubMed - indexed for MEDLINE]
17.

[Vitamin A overdosage. II. Cytological and biochemical changes in blood from high doses of vitamin A with and without alpha-tocopherol treatment].

Soliman MK.

Int J Vitam Nutr Res. 1972;42(4):576-82. German. No abstract available.

PMID:
4644617
[PubMed - indexed for MEDLINE]
18.

Severe coagulopathy in young chickens produced by ochratoxin A.

Doerr JA, Huff WE, Hamilton PB, Lillehoj EB.

Toxicol Appl Pharmacol. 1981 Jun 15;59(1):157-63. No abstract available.

PMID:
7256754
[PubMed - indexed for MEDLINE]
19.

[Some parameters of blood clotting in neoplastic diseases].

Panecka A, Korolko A, Uchacz M, Pozarowski A, Geca C.

Pol Tyg Lek. 1971 May 24;26(21):782-4. Polish. No abstract available.

PMID:
5560119
[PubMed - indexed for MEDLINE]
20.

Factor VII survival studies in factor VII Padua abnormality.

Girolami A, Toffanin F, Gazzetta R.

Acta Haematol. 1980;63(6):333-5.

PMID:
6774569
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk